HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,262,319 | +3.0% | 137,739 | -2.7% | 1.25% | +14.1% |
| Q2 2023 | $5,106,827 | +15.9% | 141,581 | +22.6% | 1.10% | +12.5% |
| Q1 2023 | $4,408,067 | -37.9% | 115,470 | -7.3% | 0.97% | -38.9% |
| Q4 2022 | $7,098,112 | +19.1% | 124,572 | -17.4% | 1.59% | +15.7% |
| Q3 2022 | $5,961,000 | -21.2% | 150,755 | -12.3% | 1.38% | -13.5% |
| Q2 2022 | $7,568,000 | -35.5% | 171,969 | -41.6% | 1.59% | -9.4% |
| Q1 2022 | $11,737,000 | -1.3% | 294,413 | -0.4% | 1.76% | +13.4% |
| Q4 2021 | $11,890,000 | – | 295,656 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |